MedTest Dx Releases a New Line of ClinitoxTM Calibrators and Controls for Drugs of Abuse Toxicology Testing at 2019 AACC Scientific Meeting
MedTest Dx, Inc., a name synonymous with drugs of abuse toxicology confirmation testing products through its ClinitoxTM brand, today announced it will introduce an improved line of Clinitox Calibrators and Controls for confirmation testing at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. The new product line provides laboratories performing confirmation testing a comprehensive, reliable, easy-to-use and customizable calibration and controls solution designed for accuracy and efficiency, with extended shelf life and simplified documentation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190801005092/en/
MedTest Dx Releases a New Line of Clinitox Calibrators and Controls for Drugs of Abuse Toxicology Testing at 2019 AACC Scientific Meeting (Photo: Business Wire)
Confirmation testing is an essential part of the two-step process used for drugs of abuse toxicology testing, a segment that has experienced substantial growth in recent years. Positive results from drug screening tests are typically re-tested using LC/MS mass spectrometry technology, which confirms the initial results and provides additional information with high accuracy.
“These latest improvements to our Clinitox Calibrators and Controls were a direct result of our relentless focus on the question ‘What would our customers want?’” said Wayne Brinster, Chief Executive Officer of MedTest Dx. “This focus also led us to offer a complete turnkey solution to make drugs of abuse confirmation testing fast, easy and accurate. By eliminating the need to acquire and set-up materials, conduct multiple handling and measuring steps and manage controls and certifications, we save our customers a great deal of time and money. These solutions are also customizable, enabling them to be tailored to a laboratory’s specific needs. Best of all, they embody our well-established commitments to quality and customer support.”
Clinitox Calibrators and Controls are ready-to-use, liquid formats that simplify calibration and quality control procedures. They can be fully customized to meet the unique needs of individual laboratories, taking into consideration specific testing requirements, LC/MS instrumentation and sample matricies. Custom profiles are easily edited or updated as needs change. Clinitox Calibrators and Controls come as ready-to-use single use ampoules with batch and lot certifications, ensuring they deliver the quality laboratories require.
The MedTest Dx Clinitox Solution is a comprehensive key system enabling labs to bring drugs of abuse confirmation testing in-house by increasing the ease and efficiency of confirmation testing, while reducing the cost. It provides streamlined sample preparation; rapid implementation; Certificates of Analysis; documentation for traceability, including routine or specialty compound cut-offs; multiple panel options; and custom LC/MS calibrators, controls and internal standards.
To learn more about how MedTest Dx’s integrated solutions can strengthen and support your clinical laboratory services, visit AACC 2019 Booth #1567.
About MedTest Dx
MedTest Dx is your Solution Provider of Choice for clinical diagnostic testing. We have a unique combination of screening instruments, reagent manufacturing, world class service capabilities and full LC/MS toxicology confirmation products. We have a globally recognized reagent manufacturing organization to meet scientific and regulatory needs as well as a service organization with an impeccable reputation in chemistry, toxicology, and hematology. We have reliable, scalable, state-of-the-art, low-cost instrumentation that meets the needs of customers with restrictive budgets. We challenge ourselves every day with the question “What Would our Customers Want?” Through this relentless customer advocacy, we strive to deliver the best solutions to our customers’ daily challenges. For more information, visit medtestdx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005092/en/
